- Maintenance of abstinence in alcohol dependent patients:
- PO 666mg TDS
- Initiated ASAP following the period of alcohol withdrawal when the patient has achieved abstinence and should be maintained if patient relapses.
- Tablet:
- 333mg
- Can be taken with or without food
GABA Agonist/Glutamate Antagonist
Not fully understood but thought to restore balance between neuronal excitation and inhibition via effects on GABA and glutamate.
- Diarrhea
- Insomnia
- Anxiety
- Depression
- Asthenia
- Nausea
- Pruritus
- Dizziness
- Diaphoresis
- Paresthesia
- Xerostomia
- Pain
- Hypersensitivity to drug/components
- Severe renal impairment (CrCl <30)
- None remarkable
Drug Status
| Availability | Prescription only |
| Pregnancy | Contraindicated |
| Breastfeeding | Benefit outweighs risk |
| Schedule | Not controlled |
| BRAND NAME | STRENGTH | FORMULATION | PACK SIZE | MANUFACTURER | DISTRIBUTOR |
|---|---|---|---|---|---|
| Campral | 333mg | Tablet | 168’s | Merck Ltd | Merck Ltd |